Contribution of recombination to the evolutionary history of HIV
S Vuilleumier, S Bonhoeffer - Current Opinion in HIV and AIDS, 2015 - journals.lww.com
HIV recombinants increase worldwide and invade geographical regions where pure
subtypes were previously predominant. This trend is expected to continue in the future, as …
subtypes were previously predominant. This trend is expected to continue in the future, as …
Infecting HIV-1 subtype predicts disease progression in women of sub-Saharan Africa
CM Venner, I Nankya, F Kyeyune, K Demers, C Kwok… - …, 2016 - thelancet.com
Introduction Long-term natural history cohorts of HIV-1 in the absence of treatment provide
the best measure of virulence by different viral subtypes. Methods Newly HIV infected …
the best measure of virulence by different viral subtypes. Methods Newly HIV infected …
Romania, a Harbour of HIV-1 Subtype F1: Where Are We after 33 Years of HIV-1 Infection?
M Preda, LCS Manolescu - Viruses, 2022 - mdpi.com
Infection with the human immunodeficiency virus (HIV) has been a major public health
concern worldwide for more than 30 years, including in Romania. The F1 HIV-1 subtype was …
concern worldwide for more than 30 years, including in Romania. The F1 HIV-1 subtype was …
Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014–15
E Bissio, MG Barbás, MB Bouzas… - Journal of …, 2016 - academic.oup.com
Background In Argentina, current national guidelines recommend starting with NNRTI-based
regimens. Recently, there have been some local reports regarding concerning levels of …
regimens. Recently, there have been some local reports regarding concerning levels of …
Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans
DM Tebit, G Nickel, R Gibson, M Rodriguez… - Ebiomedicine, 2024 - thelancet.com
Background Simian immunodeficiency viruses (SIV) have been jumping between non-
human primates in West/Central Africa for thousands of years and yet, the HIV-1 epidemic …
human primates in West/Central Africa for thousands of years and yet, the HIV-1 epidemic …
Genetic characterization of human immunodeficiency virus type 1 transmission in the Middle East and North Africa
M Sallam, GÖ Şahin, M Ingman, A Widell… - Heliyon, 2017 - cell.com
Background The HIV-1 spread in the Middle East and North Africa (MENA) has not been
previously characterised using the phylogenetic approach. The aim of the current study was …
previously characterised using the phylogenetic approach. The aim of the current study was …
Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors
P Cid-Silva, L Margusino-Framiñán, V Balboa-Barreiro… - Aids, 2018 - journals.lww.com
Abstract HIV-1 subtype B (54.4%) and subtype F (27.2%) are the most prevalent variants in
patients who started antiretroviral therapy including an integrase inhibitor in the last 2 years …
patients who started antiretroviral therapy including an integrase inhibitor in the last 2 years …
Near full-length characterization and population dynamics of the human immunodeficiency virus type I circulating recombinant form 42 (CRF42_BF) in Luxembourg
D Struck, F Roman, S De Landtsheer… - AIDS Research and …, 2015 - liebertpub.com
A new recombinant form representing a mosaic of HIV-1 subtype B and F1 and designated
as CRF42_BF was identified in Luxembourg. We confirmed the inedited nature of …
as CRF42_BF was identified in Luxembourg. We confirmed the inedited nature of …
HIV-1 group O genotypes and phenotypes: relationship to fitness and susceptibility to antiretroviral drugs
DM Tebit, H Patel, A Ratcliff, E Alessandri… - AIDS research and …, 2016 - liebertpub.com
Despite only 30,000 group O HIV-1 infections, a similar genetic diversity is observed among
the O subgroups H (head) and T (tail)(previously described as subtypes A, B) as in the 9 …
the O subgroups H (head) and T (tail)(previously described as subtypes A, B) as in the 9 …
Deciphering how HIV1 intersubtype recombination shapes viral fitness and disease progression
G Turk, MG Carobene - EBioMedicine, 2015 - thelancet.com
Extreme genetic variability is the hallmark of HIV1 infection and it represents a major
challenge for antiviral treatment and vaccine development. HIV1 group M dominates the …
challenge for antiviral treatment and vaccine development. HIV1 group M dominates the …